Risedronate Sodium 00430-0970
Product NDC
00430-0970- Manufacturer
- Allergan, Inc.
- Dosage Form
- Tablet, Delayed Release
- Product Type
- Drug For Further Processing
- Marketing Start
- December 1, 2010
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risedronate Sodium Hemi-Pentahydrate | 30.1 mg/1 |
| Risedronate Sodium Monohydrate | 4.9 mg/1 |
Packaging Options(1)
22792 TABLET, DELAYED RELEASE in 1 DRUM (0430-0970-00)